SCHEMBL10109209

SCHEMBL10109209

Cc1sc(-c2ccccc2)c(-c2ccccc2)c1-c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.42
GRM6 O15303 2/20 0.41
MAPT P10636 5/20 0.41
KDM4E B2RXH2 3/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
CHEK1 O14757 1/20 0.41
AKT2 P31751 1/20 0.41
MAPK1 P28482 2/20 0.40
ALDH1A1 P00352 4/20 0.39
HPGD P15428 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
HTT P42858 2/20 0.38
LMNA P02545 2/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13337266 0.85 AKT2 (0.46) ALOX5MAPTKDM4ECHEK1AKT2
SCHEMBL10690630 0.84 ALOX5 (0.41) ALOX5GRM6MAPTCHEK1AKT2
SCHEMBL1224397 0.83 MAPT (0.56) ALOX5GRM6MAPTKDM4ECYP1A2
SCHEMBL12262883 0.80 ALOX5 (0.51) ALOX5GRM6MAPTKDM4ECYP1A2
SCHEMBL12545005 0.78 MAPK1 (0.36) ALOX5MAPTKDM4ECHEK1AKT2
SCHEMBL12545257 0.75 MAPK1 (0.35) ALOX5MAPTKDM4ECYP1A2CYP3A4
SCHEMBL20130339 0.75 ALOX5 (0.39) ALOX5GRM6MAPTKDM4ECYP1A2
Bicarbonate SCHEMBL8752125 0.74 MAPT (0.48) ALOX5GRM6MAPTKDM4ECYP1A2
SCHEMBL28123162 0.74 MAPT (0.48) ALOX5GRM6MAPTKDM4ECYP1A2
SCHEMBL13093559 0.74 CHEK1 (0.42) MAPTKDM4ECHEK1AKT2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115975115-A Preparation method of quantum dot fluorescent microspheres, quantum dot fluorescent microspheres and application 广东粤港澳大湾区国家纳米科技创新研究院 2023-04-18 CN claimed
US-20120074395-A1 ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2012-03-29 US disclosed
US-20120074395-A1 ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2012-03-29 US disclosed
US-20100025661-A1 Luminescent material and organic electroluminescent device using the same JNC CORPORATION (JP) 2010-02-04 US disclosed
US-20100025661-A1 Luminescent material and organic electroluminescent device using the same JNC CORPORATION (JP) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100025661-A1 Luminescent material and organic electroluminescent device using the same TRPV3, TRPC3, HVCN1 ALOX5 3401/4885GRM6 3432/4885MAPT 2357/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.